Get started
TWIST BIOSCIENCE CORPORATIONTWIST BIOSCIENCE CORPORATIONTWIST BIOSCIENCE CORPORATION

TWIST BIOSCIENCE CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0ME chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪2.27 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.10EUR
Net income (FY)
‪−193.57 M‬EUR
Revenue (FY)
‪231.87 M‬EUR
Shares float
‪55.70 M‬
Beta (1Y)
4.35

About Twist Bioscience Corporation

Sector
Health Technology
Industry
Biotechnology
CEO
Emily Marine Leproust
Website
twistbioscience.com
Headquarters
San Francisco
Employees (FY)
919
Founded
2013
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck on February 4, 2013 and is headquartered in San Francisco, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0ME is 38.32 EUR — it has decreased by 1.79% in the past 24 hours. Watch TWIST BIOSCIENCE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange TWIST BIOSCIENCE CORPORATION stocks are traded under the ticker 0ME.
0ME stock has fallen by 11.09% compared to the previous week, the month change is a 32.50% rise, over the last year TWIST BIOSCIENCE CORPORATION has showed a 177.48% increase.
We've gathered analysts' opinions on TWIST BIOSCIENCE CORPORATION future price: according to them, 0ME price has a max estimate of 51.11 EUR and a min estimate of 26.02 EUR. Watch 0ME chart and read a more detailed TWIST BIOSCIENCE CORPORATION stock forecast: see what analysts think of TWIST BIOSCIENCE CORPORATION and suggest that you do with its stocks.
0ME reached its all-time high on Jan 21, 2021 with the price of 175.00 EUR, and its all-time low was 10.45 EUR and was reached on May 5, 2023. View more price dynamics on 0ME chart.
See other stocks reaching their highest and lowest prices.
0ME stock is 1.83% volatile and has beta coefficient of 4.35. Track TWIST BIOSCIENCE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is TWIST BIOSCIENCE CORPORATION there?
Today TWIST BIOSCIENCE CORPORATION has the market capitalization of ‪2.27 B‬, it has increased by 29.08% over the last week.
Yes, you can track TWIST BIOSCIENCE CORPORATION financials in yearly and quarterly reports right on TradingView.
TWIST BIOSCIENCE CORPORATION is going to release the next earnings report on Aug 2, 2024. Keep track of upcoming events with our Earnings Calendar.
0ME earnings for the last quarter are −0.73 EUR per share, whereas the estimation was −0.76 EUR resulting in a 3.15% surprise. The estimated earnings for the next quarter are −0.71 EUR per share. See more details about TWIST BIOSCIENCE CORPORATION earnings.
TWIST BIOSCIENCE CORPORATION revenue for the last quarter amounts to ‪69.79 M‬ EUR despite the estimated figure of ‪65.52 M‬ EUR. In the next quarter revenue is expected to reach ‪71.17 M‬ EUR.
0ME net income for the last quarter is ‪−42.16 M‬ EUR, while the quarter before that showed ‪−38.97 M‬ EUR of net income which accounts for −8.20% change. Track more TWIST BIOSCIENCE CORPORATION financial stats to get the full picture.
No, 0ME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 27, 2024, the company has 919.00 employees. See our rating of the largest employees — is TWIST BIOSCIENCE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TWIST BIOSCIENCE CORPORATION EBITDA is ‪−145.65 M‬ EUR, and current EBITDA margin is −72.45%. See more stats in TWIST BIOSCIENCE CORPORATION financial statements.
Like other stocks, 0ME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TWIST BIOSCIENCE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TWIST BIOSCIENCE CORPORATION technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TWIST BIOSCIENCE CORPORATION stock shows the buy signal. See more of TWIST BIOSCIENCE CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.